Figures computed from official regulatory filings — .
Analysttarget 49 USD (+111%) · consensus 4.5/5 · 7 buy · 1 hold · 0 sell
Ownershipinsiders 1.15% · institutions 130.04% · short 20.2% of float
In USD · as of Oct 19, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for COLLEGIUM PHARMACEUTICAL, INC only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone for the management of pain severe enough to require daily; Nucynta ER and Nucynta IR, which are extended-release and immediate-release oral formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. Collegium Pharmaceutical, Inc. was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. The company was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
Market information source · Oct 19, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 19, 2026
Open-market timeline · full history
11 buys189 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| SANTINI GINO | Exercise | $143.5K | SEC |
| SANTINI GINO | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Freund John Gordontrack record | Sell | $681 | SEC |
| SANTINI GINO | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Balice-Gordon Rita J. | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Lurker Nancytrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Freund John Gordontrack record | Exercise | $143.5K | SEC |
| BOHLIN GAREN G | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Freund John Gordontrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Glancy Donovan Michael | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Freund John Gordontrack record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Paya Carlos V | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Freund John Gordontrack record | Sell | $142.5K | SEC |
| Lurker Nancytrack record | Sell | $161.9K | SEC |
| BOHLIN GAREN G | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| BOHLIN GAREN G | Exercise | $143.5K | SEC |
| BOHLIN GAREN G | Sell | $323.5K | SEC |
| Dieter David | Other | $315.8K | SEC |
| Dieter David | Sell | $488K | SEC |
| Dieter David | Sell | $228.1K | SEC |
| Dreyer Scott | Sell | $1.9M | Unusual size | SEC |
| Dreyer Scott | Sell | $145.9K | SEC |
| Karnani Vikram | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Karnani Vikram | Other | $528.1K | SEC |
| Dieter David | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |